Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer (ProVent)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03686683
Recruitment Status : Active, not recruiting
First Posted : September 27, 2018
Last Update Posted : October 10, 2019
Sponsor:
Collaborator:
PRA Health Sciences
Information provided by (Responsible Party):
Dendreon

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2023
Estimated Study Completion Date : May 2023